🌐All research

Yale-led technology receives FDA approval for breast cancer treatment

“The biotech company Arvinas was originally founded based on pioneering research from Yale chemist Craig Crews into PROTAC protein degraders.

Original story

Continue reading at Yale News

news.yale.edu

Read full article

Summary generated from the RSS feed of Yale News. All article rights belong to the original publisher. Click through to read the full piece on news.yale.edu.

Yale-led technology receives FDA approval for breast cancer treatment

Similar stories — research

„Wann werden diese Ruinen renoviert, die sich Universitäten nennen?“: Das Ausmaß des Sanierungsstaus an deutschen Hochschulen

Lack of social capital a barrier for Malay community despite signs of rising educational mobility: Study

Infektionen auf Schiff: WHO-Chef: Elf Fälle nach Hantavirus-Ausbruch auf „Hondius“

Imagining the ‘oral essay’, or why universities should make more room for thinking aloud

TCM tuina therapy as effective as physiotherapy for short-term relief of lower back pain: SGH study

US schools are winning the phone-use battle, but not the learning war